Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2026-01-01 @ 6:19 AM
Study NCT ID:
NCT04510493
Status:
COMPLETED
Last Update Posted:
2021-09-08
First Post:
2020-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020-02008; me20Donath2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None